Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Preparation method of tulathromycin powder for treating colibacillosis

A technology of telamycin powder and colibacillosis, which is applied in the field of medicine, can solve the problems of ineffective treatment and achieve the effect of long-lasting drug effect, rapid absorption and long half-life

Inactive Publication Date: 2014-12-10
苏赵珍
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

So many sensitive drugs can't achieve the therapeutic effect

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0013] 2% w / w as Tyramycin, Tyramycin Soluble Powder Preparation:

[0014] a. 2% w / w based on telamycin, telamycin tartrate

[0015] b. Carrier: dextrin 200g, sucrose up to 1000g.

[0016] Preparation steps: take sucrose and pulverize it, mix it with 31.17 g of telamycin tartrate and dextrin, dry it, and pass it through an 80-mesh sieve to obtain the product.

Embodiment 2

[0018] 5% w / w as Tyramycin, Tyramycin Soluble Powder Preparation:

[0019] a. 5% w / w based on telamycin, telamycin phosphate

[0020] b, glucose powder to 1000g.

[0021] Preparation steps: take 68.36 g of telamycin phosphate and glucose powder, mix evenly, pulverize, and pass through an 80-mesh sieve to obtain the product.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a preparation method of tulathromycin powder for treating colibacillosis. The preparation method comprises the following steps: adding 1-20% of tulathromycin phosphorate and 0-0.5mmol / g of a cosolvent to a carrier; and evenly mixing, drying, and screening the raw materials by an 80-mesh sieve. The tulathromycin disclosed by the invention is quickly absorbed after drug administration, and has the advantages of high bioavailability, long half-life period, lasting pharmacological effect and relatively high safety, and is suitable for the requirements of livestock husbandry development.

Description

technical field [0001] The invention belongs to the field of medicine and relates to a telamycin soluble powder for treating colibacillosis. Background technique [0002] The application of antibacterial drugs to treat colibacillosis is still the main treatment measure at present: commonly used antibiotics, quinolones, sulfonamides, furans and other antibacterial and anti-inflammatory drugs have certain curative effects on colibacillosis. However, due to the long-term or high-dose abuse of antibacterial drugs in many chicken farms, especially the repeated prophylaxis of high concentrations has induced the emergence of many resistant strains of Escherichia coli. Make a lot of originally sensitive medicines but can't achieve the effect of treatment. [0003] Colibacillosis is a common and frequently-occurring disease caused by Escherichia coli. Including Escherichia coli peritonitis, salpingitis, omphalitis, synovitis, air sacitis, granuloma, ophthalmia and other diseases, w...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/14A61K31/7052A61P31/04
Inventor 不公告发明人
Owner 苏赵珍
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com